NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Cited by (862)

Items 201–300 of 862

1. Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis
   Valentina Pinzi, Chiara Orsi, Marcello Marchetti, Ida Maddalena Milanesi, Livia Corinna Bianchi, Francesco DiMeco, Valeria Cuccarini, Mariangela Farinotti, Paolo Ferroli, Gaetano Finocchiaro et al. · 2015 · Neurological Sciences
2. Angiogenesis inhibitors in tackling recurrent glioblastoma
   Thomas Hundsberger, David A. Reardon, Patrick Yung Wen · 2017 · Expert Review of Anticancer Therapy
3. Contemporary management of high-grade gliomas
   Hao‐Wen Sim, Erin R Morgan, Warren P. Mason · 2017 · CNS Oncology
4. Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data
   Daniela Annenelie Bota, Warren P. Mason, Santosh Kesari, Rajiv Magge, Benjamin Winograd, Ileana Elias, Steven D. Reich, Nancy Levin, Mohit Trikha, Annick Desjardins · 2021 · Neuro-Oncology Advances
5. Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors
   Laura M. Benson · 2018 · Seminars in Oncology Nursing
6. Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: A systematic review
   Alja Zottel, Ivana Jovčevska, Neja Šamec, Radovan Komel · 2021 · Critical Reviews in Oncology/Hematology
7. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds
   Sweety Asija, Abhishek Chatterjee, Sandhya Yadav, Godhanjali Chekuri, Atharva Karulkar, Ankesh Kumar Jaiswal, Jayant Sastri Goda, Rahul Purwar · 2022 · International Reviews of Immunology
8. Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
   Estela Pineda, Marta Doménech, Ainhoa Hernández, Silvia Comas, Carmen Balañá · 2023 · OncoTargets and Therapy
9. Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma
   Yoshiaki Maruyama, Akira Sakurai, Shinichi Noda, Yasuhiro Fujiwara, Narumi Okura, Toshinori Takagi, Junichi Asano, Futaba Honda · 2023 · The Oncologist
10. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes
    Azeem A. Rehman, Kevin B. Elmore, Tobias A. Mattei · 2015 · Neurosurgical FOCUS
11. Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis
    Mihir Shanker, Benjamin Chua, Catherine S. Bettington, Matthew C. Foote, Mark Blayne Pinkham · 2018 · Neuro-Oncology Practice
12. Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma
    Axel H. Schönthal, David M. Peereboom, Naveed A. Wagle, Rose Lai, Anna J. Mathew, Kyle M. Hurth, Vincent F. Simmon, Steven Howard, Lynne Patricia Taylor, Frances Elaine Chow et al. · 2021 · Neuro-Oncology Advances
13. DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies
    Ola Rominiyi, Spencer James Collis · 2021 · Molecular Oncology
14. 5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
    Yeon‐Joo Lee, Jae-Min Cho, Sei Sai, Ju Yeon Oh, Ji Ae Park, Se Jong Oh, Misun Park, Junhye Kwon, Ui Sup Shin, Jeong-Hwa Baek et al. · 2019 · Cancers
15. The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices
    Federica Di Cintio, Michele Dal Bo, Lorena Baboçi, Elena De Mattia, Maurizio Polano, Giuseppe Toffoli · 2020 · Frontiers in Neuroscience
16. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma
    Antonio Dono, Sonali Mitra, Mauli Shah, Takeshi Takayasu, Jay‐Jiguang Zhu, Nitin Tandon, Chirag B. Patel, Yoshua Esquenazi, Leomar Y. Ballester · 2021 · Journal of Neuro-Oncology
17. Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
    Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, Matteo Sacco, Matteo Landriscina, Giovanni Parbonetti, Matteo de Notaris, Giulia Coppola, Elena De Santis, Guido Giordano et al. · 2022 · Biomedicines
18. Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial
    John Howard Sampson, Achal Singh Achrol, Manish Kumar Aghi, Krystof S. Bankiewicz, Martin Bexon, Steven S. Brem, Andrew Jacob Brenner, Chandtip Chandhasin, Sajeel A. Chowdhary, Melissa Coello et al. · 2023 · Neuro-Oncology
19. Advancements and challenges in brain cancer therapeutics
    Fan Bai, Yueyang Deng, Long Li, Ming Lv, Jamoliddin Razzokov, Qingnan Xu, Zhen Xu, Zhaowei Chen, Guojun Chen, Zhitong Chen · 2024 · Exploration
20. Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage
    Colette J. Shen, Megan N. Kummerlowe, Kristin Janson Redmond, Juan Carlos Martínez-Gutiérrez, Syed Muhammad Usama, Matthias Holdhoff, Stuart A. Grossman, John Laterra, Roy Ervin Strowd III, Lawrence Richard Kleinberg · 2018 · Advances in Radiation Oncology
21. Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice
    Tonia C. Carter, Rafael Medina‐Flores, Benjamin Lawler · 2018 · BioMed Research International
22. Central Nervous System Cancers
    Steven S Brem, Philip J Bierman, Peter McL. Black, Henry Brem, Marc C Chamberlain, Ennio Antonio Chiocca, Lisa M DeAngelis, Robert A Fenstermaker, Allan Friedman, Mark R Gilbert et al. · 2008 · Journal of the National Comprehensive Cancer Network
23. Gliomas in adults: Guidance on investigations, diagnosis, treatment and surveillance
    A. Lerner, Kieran R. Palmer, Tom Campion, Thomas O Millner, Emily Scott, C. Lorimer, Dimitrios Paraskevopoulos, Grainne S. McKenna, Silvia Marino, R. Lewis et al. · 2024 · Clinical Medicine
24. Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
    Sergey V. Roussakow · 2017 · BMJ Open
25. The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis
    Yuhang Zhao, Xinghuan Wang, Changjun Cao, Hong Weng, Chengshi Xu, Kai Li, Jie-Li Li, Jing Quan Lan, Xian‐Tao Zeng, Zhiqiang Li · 2018 · Frontiers in Neurology
26. Tumor-Treating Fields Induce RAW264.7 Macrophage Activation Via NK-κB/MAPK Signaling Pathways
    Jeong‐In Park, Kyung‐Hee Song, Seung-Youn Jung, Jiyeon Ahn, Sang‐Gu Hwang, Joon Kim, Eun Ho Kim, Jie Young Song · 2019 · Technology in Cancer Research & Treatment
27. Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates
    Rhea Arvind, Sreenivasa Rao Chandana, Mitesh J. Borad, Daniel Pennington, Kabir Mody, Hani M. Babiker · 2021 · Critical Reviews in Oncology/Hematology
28. How to train glioma cells to die: molecular challenges in cell death
    Jeffrey Wojton, Walter Hans Meisen, Balveen Kaur · 2015 · Journal of Neuro-Oncology
29. OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma
    Anders Rosendal Korshoej, Slávka Lukacova, Yasmin Lassen–Ramshad, Christian Rahbek, Kåre Eg Severinsen, Trine Lignell Guldberg, Nikola Mikic, Mette Haldrup Jensen, Søren Cortnum, Gorm von Öettingen et al. · 2020 · Neuro-Oncology Advances
30. Advances of Electroporation-Related Therapies and the Synergy with Immunotherapy in Cancer Treatment
    Xuan Gong, Zhou Chen, Jason J. Hu, Chao Liu · 2022 · Vaccines
31. An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
    Wong, Eric T, Lok, Edwin, Swanson, Kenneth D. · 2015 · Current Treatment Options in Oncology
32. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art
    Mateusz Pinkiewicz, Miłosz Pinkiewicz, Jerzy Michał Walecki, Michał Zawadzki · 2022 · Frontiers in Oncology
33. Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma
    Gloria Miguel Llordes, Víctor Manuel Medina Pérez, Beatriz Curto Simón, Irene Castells-Yus, Silvia Vázquez Sufuentes, Alberto J. Schuhmacher · 2023 · Journal of Clinical Medicine
34. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system
    Scott Turner, Thomas Gergel, Hueizhi Wu, Michel Lacroix, Steven A. Toms · 2014 · World Journal of Surgical Oncology
35. Tumour treating fields in a combinational therapeutic approach
    Joshua Branter, Surajit Basu, Stuart James Smith · 2018 · Oncotarget
36. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report
    Victor M. Lu, Ashish Harish Shah, Frederic Anthony Vallejo, Daniel G. Eichberg, Evan Luther, Sumedh Subodh Shah, Ricardo J. Komotar, Michael E. Ivan · 2021 · Neurosurgical FOCUS
37. Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis
    Ohad Regev, Vladimir Merkin, Deborah T. Blumenthal, Israel Melamed, Tehila Kaisman‐Elbaz · 2021 · Neuro-Oncology Practice
38. Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation
    Luca Giovanni Campana, ADIL I. DAUD, Francesco Lancellotti, Julio P. Arroyo, Rafael V. Davalos, Claudia Di Prata, Julie Gehl · 2023 · Cancers
39. The treatment of glioblastomas: A systematic update on clinical Phase III trials
    Anan Yin, Jinxiang Cheng, Xiang Zhang, Bo-lin Liu · 2013 · Critical Reviews in Oncology/Hematology
40. Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study
    Dongjiang Chen, Son B Le, Ashley Parham Ghiaseddin, Harshit Manektalia, Ming Li, Adam O’Dell, Maryam Rahman, David Dinh Tran · 2025 · Med
41. The future of high-grade glioma: Where we are and where are we going
    Marc Charles Chamberlain, Émilie Le Rhun, Sophie Taillibert · 2015 · Surgical Neurology International
42. Tubulin's response to external electric fields by molecular dynamics simulations
    Joshua J. Timmons, Jordane Preto, Jack A. Tuszyński, Eric T. Wong · 2018 · PLoS ONE
43. High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes
    Fanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, Nadine Benhamouda, Charlotte Taboas, Fabien Gueugnon, Thi Tran, Hervé Nozach, Elodie Marcon, Alain Gey et al. · 2018 · Frontiers in Oncology
44. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
    Andrew Jehyun Song, David William Andrews, Maria Werner‐Wasik, Lyndon Kim, Jon Glass, Voichita Bar‐Ad, James J. Evans, Christopher James Farrell, Kevin D Judy, Constantine Daskalakis et al. · 2019 · Radiotherapy and Oncology
45. In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
    Roni Blatt, Shiri Davidi, Mijal Munster, Anna Shteingauz, Shay Cahal, Adel Zeidan, Tal Marciano, Zéev Bomzon, Adi Haber, Moshe Giladi et al. · 2021 · Frontiers in Oncology
46. Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors
    Kyle Richard Noll, Amanda L. King, Linda Dirven, Terri S. Armstrong, MARTIN J.B. TAPHOORN, Jeffrey Scott Wefel · 2021 · Hematology/Oncology Clinics of North America
47. Triboelectric Current Stimulation Alleviates In Vitro Cell Migration And In Vivotumor Metastasis
    Binbin Chu, Xuan Qin, Qianqian Zhu, Houyu Wang, Zhen Wen, Xuhui Sun, Yao He, Shuit‐Tong Lee · 2022 · Nano Energy
48. Is extremely low frequency pulsed electromagnetic fields applicable to gliomas? A literature review of the underlying mechanisms and application of extremely low frequency pulsed electromagnetic fields
    Mengqian Huang, Parker Li, Feng Chen, Zehao Cai, Shoubo Yang, Xiaohong Zheng, Wenbin Li · 2022 · Cancer Medicine
49. Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
    Hila Fishman, Roni Monin, Eyal Dor-On, Adrian Kinzel, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti · 2023 · Journal of Neuro-Oncology
50. Targeting drug resistance in glioblastoma (Review)
    Jonathan H. Sherman, A Bobak, Tasneem A. Arsiwala, Paul R. Lockman, Sonikpreet Aulakh · 2024 · International Journal of Oncology
51. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
    Yuefeng Wang, Manjari K Pandey, Matthew T. Ballo · 2019 · The Oncologist
52. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma
    Andrew Jehyun Song, Voichita Bar‐Ad, Nina Martinez, Jon Glass, David William Andrews, Kevin D Judy, James J. Evans, Christopher James Farrell, Maria Werner‐Wasik, Inna Chervoneva et al. · 2020 · Journal of Neuro-Oncology
53. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
    Nika Guberina, Christoph Pöttgen, Sied Kebir, Lazaros Lazaridis, C. Scharmberg, Wolfgang Lübcke, M. Niessen, Maja Guberina, Björn Scheffler, Verena Jendrossek et al. · 2020 · Radiation Oncology
54. Heat transfer during TTFields treatment: Influence of the uncertainty of the electric and thermal parameters on the predicted temperature distribution
    Nichal Gentilal, Pedro Cavaleiro Miranda · 2020 · Computer Methods and Programs in Biomedicine
55. Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
    Andres Vargas‐Toscano, Ann‐Christin Nickel, Guanzhang Li, Marcel Alexander Kamp, Sajjad Muhammad, Gabriel Leprivier, Ellen Fritsche, Roger A. Barker, Michael Sabel, Hans‐Jakob Steiger et al. · 2020 · Cancers
56. Medical Device Advances in the Treatment of Glioblastoma
    Cher Ying Foo, Nimrah Munir, Ashwin Kumaria, Qasim Akhtar, Christopher J. Bullock, Ashwin Narayanan, Richard Zhiming Fu · 2022 · Cancers
57. Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
    Silvia Salerno, Elisabetta Barresi, Emma Baglini, Valeria Poggetti, Federico Da Settimo, Sabrina Taliani · 2023 · Molecules
58. DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
    Lidia Gatto, Vincenzo Di Nunno, Alicia Tosoni, Stefania Bartolini, Lucia Ranieri, Enrico Franceschi · 2023 · Cancers
59. SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022)
    Pedro Pérez‐Segura, N. Vilariño Quintela, Maria Martinez‐García, Sonia Del Barco, Regina Gironés Sarrió, Jesús García Gómez, Almudena García Castaño, M Navarro, Oscar S. Gallego, Estela Pineda Losada · 2023 · Clinical & Translational Oncology
60. Clinical benefit in recurrent glioblastoma from adjuvant Novo TTF ‐100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation
    Eric T. Wong, Edwin Lok, Kenneth D. Swanson · 2015 · Cancer Medicine
61. Pivotal therapeutic trials for infiltrating gliomas and how they affect clinical practice
    Rimas Vincas Lukas, Maciej M. Mrugała · 2016 · Neuro-Oncology Practice
62. Skin toxicities associated with tumor treating fields: case based review
    Rimas Vincas Lukas, Kelley L. Julian, Eric T. Wong, John Lee Villano · 2017 · Journal of Neuro-Oncology
63. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])
    Shadi Shams, Chirag B. Patel · 2022 · Journal of Molecular Cell Biology
64. Xenotransplantation of Human glioblastoma in Zebrafish larvae: in vivo imaging and proliferation assessment
    Luis A. Vargas-Patron, Nathalie Agudelo Dueñas, Jorge A. Madrid-Wolff, Juan A. Venegas, John Mario González, Manu Forero-Shelton, Verónica Akle · 2019 · Biology Open
65. Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device
    David S. Baskin, Martyn A. Sharpe, Lisa L.H. Nguyen, Santosh A. Helekar · 2021 · Frontiers in Oncology
66. Locked and Loaded: β-Galactosidase Activated Photodynamic Therapy Agent Enables Selective Imaging and Targeted Treatment of Glioblastoma Multiforme Cancer Cells
    Toghrul Almammadov, Zübeyir Elmazoğlu, Gizem Atakan Alkan, Dilay Kepil, Güzide Aykent, Safacan Kölemen, Gorkem E. Gunbas · 2022 · ACS Applied Bio Materials
67. A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial
    Divyalakshmi Bhaskaran, Joshua S. Savage, Amit N. Patel, Fiona Jane Collinson, Rhys Mant, Florien Willemijn Boele, Lucy Brazil, Sara Meade, Peter Buckle, Siân Lax et al. · 2024 · BMC Cancer
68. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations
    Edwin Lok, Kenneth D. Swanson, Eric T. Wong · 2015 · Expert Review of Medical Devices
69. Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts
    Enrico Franceschi, Santino Minichillo, Alba Ariela Brandes · 2017 · CNS Drugs
70. Selective toxicity of tumor treating fields to melanoma: an in vitro and in vivo study
    Yunhui Jo, Sang‐Gu Hwang, Yeung Bae Jin, Jiwon Sung, Youn Kyoung Jeong, Jeong Hwa Baek, Jae-Min Cho, Eun Ho Kim, Myonggeun Yoon · 2018 · Cell Death Discovery
71. Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study
    Eleni Gkika, Anca‐Ligia Grosu, Teresa Mercade Macarulla, Antonio Cubillo Gracián, Thomas Baptist Brunner, Michael Schultheiß, Monika Pazgan−Simon, Thomas Theodor Werner Seufferlein, Yann Touchefeu · 2022 · Cancers
72. The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
    Young Zoon Kim, Chae‐Yong Kim, Jaejoon Lim, Kyoung Su Sung, Jihae Lee, Hyuk-Jin Oh, Seok‐Gu Kang, Shin-Hyuk Kang, Doo‐Sik Kong, Sung Hwan Kim et al. · 2019 · Brain Tumor Research and Treatment
73. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview
    Michael A. Garcia, Adam Christopher Turner, David G Brachman · 2024 · Journal of Neuro-Oncology
74. Novel chemotherapeutics and other therapies for treating high-grade glioma
    Jennifer H. Kang, Cory Adamson · 2015 · Expert Opinion on Investigational Drugs
75. External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma
    Neil Kanth Taunk, Fábio Ynoe de Moraes, Freddy E. Escorcia, Lucas C. Mendez, Kathryn P. Beal, Gustavo Nader Marta · 2016 · Expert Review of Anticancer Therapy
76. Pharmacotherapies for the treatment of glioblastoma – current evidence and perspectives
    Katharina Seystahl, Dorothee Gramatzki, Patrick Roth, Michael Weller · 2016 · Expert Opinion on Pharmacotherapy
77. Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
    Zaixiang Fu, Ganggui Zhu, Chao Luo, Zihang Chen, Zhangqi Dou, Yike Chen, Zhong Chen, Sheng Su, Fuyi Liu · 2022 · Frontiers in Oncology
78. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy
    Christoph Pohling, Ha Nguyen, Edwin Chang, Keith Evan Schubert, Ying Nie, Vladimir A. Bashkirov, Vicky N. Yamamoto, Yuping Zeng, Roger Stupp, Reinhard W. Schulte et al. · 2022 · Bioelectrochemistry
79. Electricity‐Assisted Cancer Therapy: From Traditional Clinic Applications to Emerging Methods Integrated with Nanotechnologies
    Songjing Zhong, Shuncheng Yao, Qinyu Zhao, Zhuo Wang, Zhirong Liu, Linlin Li, Zhong Lin Wang · 2022 · Advanced NanoBiomed Research
80. Targeted Radionuclide Therapy in Glioblastoma
    Xiaobin Zhao, Vivianne Jakobsson, Yucen Tao, Tianzhi Zhao, Jingyan Wang, Pek‐Lan Khong, Xiaoyuan Shawn Chen, Jingjing Zhang · 2024 · ACS Applied Materials & Interfaces
81. Computed modeling of alternating electric fields therapy for recurrent glioblastoma
    Edwin Lok, Van Hua, Eric T. Wong · 2015 · Cancer Medicine
82. Effects of radiation from a radiofrequency identification (RFID) microchip on human cancer cells
    Henry C. Lai, Andy Ho Wing Chan, Narendra Prasad Singh · 2016 · International Journal of Radiation Biology
83. How We Treat Recurrent Glioblastoma Today and Current Evidence
    Caroline Chaul Barbosa, Daniel Fernandes Marques · 2019 · Current Oncology Reports
84. Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields
    Shiyu Liu, Qin Zhao, Weiyan Shi, Zhuangzhuang Zheng, Zijing Liu, Lingbin Meng, Lihua Dong, Xin Mei Jiang · 2020 · Journal of Cancer
85. Convection-enhanced delivery for high-grade glioma
    Jennifer H. Kang, Annick Desjardins · 2021 · Neuro-Oncology Practice
86. Current and promising treatment strategies in glioma
    Paulina Śledzińska, Marek G. Bebyn, Jacek Furtak, Agnieszka Koper, Krzysztof Koper · 2022 · Reviews in the Neurosciences
87. Repeat-surgery at Glioblastoma recurrence, when and why to operate?
    Genevieve Ening, Mai Thi Huynh, Kirsten Schmieder, Christopher Brenke · 2015 · Clinical Neurology and Neurosurgery
88. ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme
    Allison E. Cherry, Brian R. Haas, Alipi V. Naydenov, Susan Fung, Cong Xu, Katie Swinney, Michael Wagenbach, Jennifer P. Freeling, David A. Canton, Jonathan W. Coy et al. · 2016 · Molecular Cancer Therapeutics
89. Personalized Treatment for a Patient With aBRAFV600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma
    Silviya K. Meletath, Dean C. Pavlick, Timothy J. Brennan, Roy H. Hamilton, Juliann Chmielecki, Julia Andrea Elvin, Norma Alonzo Palma, Jeffrey S. Ross, Vincent A. Miller, Philip J. Stephens et al. · 2016 · Journal of the National Comprehensive Cancer Network
90. Temperature control in TTFields therapy of GBM: impact on the duty cycle and tissue temperature
    Nichal Gentilal, Ricardo Salvador, Pedro Cavaleiro Miranda · 2019 · Physics in Medicine and Biology
91. Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma
    Marilin Koch, Mykola I. Zdioruk, Michal Oskar Nowicki, Alec M. Griffith, Estuardo Aguilar-Córdova, Laura K. Aguilar, Brian W. Guzik, Francesca Barone, Paul Peter Tak, Katharina Schregel et al. · 2022 · Molecular Therapy — Oncolytics
92. Novel Vaccines for Glioblastoma: Clinical Update and Perspective
    Evan K. Winograd, Michael J. Ciesielski, Robert Alan Fenstermaker · 2016 · Immunotherapy
93. A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma
    Ryogo Kikuchi, Ryo Ueda, Katsuya Saito, Shunsuke Shibao, Hideaki Nagashima, Ryota Tamura, Yukina Morimoto, Hikaru Sasaki, Shinobu Noji, Yutaka Kawakami et al. · 2019 · Journal of Clinical Medicine
94. Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
    Mattia Russel Pantalone, Afsar Rahbar, Cecilia Söderberg‐Nauclér, Giuseppe Stragliotto · 2022 · Cancers
95. Hedgehog signaling regulates the development and treatment of glioblastoma (Review)
    Hongping Wang, Qun Lai, Dayong Wang, Jian Pei, Baogang Tian, Yunhe Gao, Zhaoguo Gao, Xiangdong Xu · 2022 · Oncology Letters
96. Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial
    Kris A. Smith, Peter Nakaji, Theresa Thomas, Dilini S. Pinnaduwage, Garrick L Wallstrom, Mehee Choi, Joseph M. Zabramski, Clark Chen, David G Brachman · 2022 · Neuro-Oncology
97. Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
    Ellaine Salvador, Theresa Koeppl, Julia Hörmann, Sebastian Schönhärl, Polina Bugaeva, Almuth Friederike Kessler, Małgorzata Burek, Ralf‐Ingo Ernestus, Mario Löhr, Carsten Hagemann · 2023 · Pharmaceutics
98. Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
    Porat, Yaara, Giladi, Moshe, Schneiderman, Rosa S., Blat, Roni, Shteingauz, Anna, Zeevi, Einav, Munster, Mijal, Voloshin, Tali, Kaynan, Noa, Tal, Orna et al. · 2017 · Journal of Visualized Experiments
99. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
    Nina Nelson, Angela Relógio · 2024 · npj Precision Oncology
100. Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
     Shengchao Xu, Chengke Luo, Dikang Chen, Lu Tang, Ling Chen, Zhixiong Liu · 2022 · Cell Death and Disease